By Stewart Eisenhart, Emergo Group Brazilian medical device market regulator ANVISA has signaled that a new regulation providing more flexibility for transferring medical device registrations between holders. At a recent ANVISA meeting attended by Emergo consultants, the agency announced that agreement on the final contents of the new device ownership transfer rule has been reached; […]
Anvisa
Sientra hits 52-week low on Brazil’s Silimed implant ban
Shares of Sientra (NSDQ:SIEN) plunged a further 20% today to a 52-week low after Brazilian regulator Anvisa last week suspended the production, sale and use of products made by Brazil’s Silimed, Sientra’s sole supplier of breast implants. The news follows a decision last month by the U.K.’s Medicines & Healthcare Products Regulatory Agency to suspend sales of Silimed implants, including breast, […]
